Project Detail
Interagency Autism Coordinating Committee (IACC) logo
Office of Autism Research Coordination (OARC) logo

Optimization of methods for production of both ICSI- and SCNT derived baboon embryonic stem cells  

While human embryonic stem cells may have incredible therapeutic value for treating a wide range of disorders such as Parkinson's diabetes, autism, heart disease, Alzheimer's etc., rigorous testing in animal models is necessary before any such trials can begin. In this study, researchers will develop and refine methods for producing viable embryonic stem cells from baboons. Any established stem cell lines will undergo rigorous testing to determine their pluripotency and normalcy. Baboons provide a valuable non-human primate model in which to determine the safety and efficacy of stem cells. Project Status


Funder National Institutes of Health
Fiscal Year Funding $260,102.00
Current Award Period 2010-2011
Project Number 5P51RR013986-12
Principal Investigator Schatten, Gerald
Received ARRA Funding? No
Strategic Plan Question Question 4: Which Treatments And Interventions Will Help? (Treatments)
Subcategory Model Systems/Therapeutic Targets
Strategic Plan Objective Green dot: Objective has greater than or equal to the recommended funding. 4SB. Standardize and validate at least 20 model systems (e.g., cellular and/or animal) that replicate features of ASD and will allow identification of specific molecular targets or neural circuits amenable to existing or new interventions by 2012. IACC Recommended Budget: $75,000,000 over 5 years.
Federal or Private? Federal
Institution Southwest Foundation For Biomedical Research
State/Country Texas
Web Link 1 Optimization of methods for production of both ICSI- and SCNT derived baboon embryonic stem cells (External web link)
Web Link 2 No URL available.
Web Link 3 No URL available.
History/Related Projects N/A